Stock Analiz

Teladoc Health, Inc. (TDOC) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Teladoc Health’s revenue went from $123M in fiscal 2016 to $2.5B in fiscal 2025, growth of about 39.9% a year.

Net income in fiscal 2025 was -$200M, a net margin of -7.9%; the best year in this period was 2016 with -$74M.

Over the twelve months to September 30, 2026, revenue was $2.5B and net income -$155M.

Free cash flow was $285M in fiscal 2025 and positive in 6 of the 10 years shown.

The diluted share count rose 316% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $123M162017: $233M172018: $418M182019: $553M192020: $1.1B202021: $2.0B212022: $2.4B222023: $2.6B232024: $2.6B242025: $2.5B25$2.5B
Net income
2016: -$74M162017: -$107M172018: -$97M182019: -$99M192020: -$485M202021: -$429M212022: -$13.7B222023: -$220M232024: -$1.0B242025: -$200M25-$200M
Free cash flow
2016: -$54M162017: -$37M172018: -$9M182019: $26M192020: -$58M202021: $185M212022: $173M222023: $339M232024: $283M242025: $285M25$285M
EPS (diluted)
2016: $-1.75162017: $-1.93172018: $-1.47182019: $-1.38192020: $-5.36202021: $-2.73212022: $-84.60222023: $-1.34232024: $-5.87242025: $-1.1425$-1.14

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2.5B$2.5B$2.6B$2.6B$2.4B$2.0B$1.1B$553M$418M$233M$123M
Gross profit————$1.7B$1.4B$703M$369M$289M$172M$91M
Operating income-$163M-$263M-$1.0B-$249M-$13.7B-$266M-$506M-$80M-$71M-$75M-$63M
Net income-$155M-$200M-$1.0B-$220M-$13.7B-$429M-$485M-$99M-$97M-$107M-$74M
EPS (diluted)$-0.86$-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38$-1.47$-1.93$-1.75
R&D$268M$278M$307M$349M$334M$312M$165M$65M$54M$34M$22M
Revenue growth—−1.5%−1.3%+8.1%+18.4%+85.8%+97.7%+32.4%+79.1%+89.4%+59.2%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$268M$294M$294M$350M$189M$194M-$54M$30M-$5M-$34M-$52M
Capital spending-$6M-$9M-$11M-$11M-$16M-$9M-$4M-$4M-$4M-$3M-$2M
Free cash flow$262M$285M$283M$339M$173M$185M-$58M$26M-$9M-$37M-$54M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks———————————
Stock-based pay$51M$80M$146M$202M$218M$303M$476M$67M$44M$31M$8M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$781M$1.3B$1.1B$918M$896M$787M$517M$479M$43M$50M
Debt—$1.0B$1.0B$1.6B$1.6B$1.3B$1.5B$470M$415M$207M$44M
Equity—$1.4B$1.5B$2.3B$2.3B$16.0B$15.9B$1.0B$1.0B$559M$231M
Total assets—$2.9B$3.5B$4.4B$4.3B$17.7B$17.8B$1.6B$1.5B$824M$304M
Shares (diluted)182M176M171M165M161M157M91M72M66M55M42M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin————69.1%68.0%64.3%66.7%69.2%73.6%74.0%
Operating margin-6.6%-10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%-50.9%
Net margin-6.3%-7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%-60.3%
FCF margin10.6%11.3%11.0%13.0%7.2%9.1%-5.3%4.8%-2.1%-15.9%-43.8%
ROIC—-9.2%-31.9%-5.0%-350.5%-1.2%-2.5%-4.9%-3.9%-9.8%-18.0%
ROE—-14.5%-67.2%-9.5%-591.9%-2.7%-3.0%-9.8%-9.6%-19.1%-32.1%

Frequently asked questions

What is Teladoc Health’s annual revenue?

$2.5B in fiscal 2025 and $2.5B over the twelve months to September 30, 2026.

How much profit does Teladoc Health make?

Net income was -$200M in fiscal 2025 (net margin -7.9%).

Is Teladoc Health’s revenue growing?

No: revenue fell 1.5% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.